MARKET PULSE-Merck, Clovis, Crocs, Burger King, Zogenix, Dendreon

Mon Oct 28, 2013 10:03am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

(For more market insights, including options activity, click on ; for the Day Ahead newsletter; for the Morning News Call newsletter,

Oct 28 (Reuters) - U.S. stocks opened flat on Monday as investors found few reasons to keep pushing shares higher after the S&P 500 climbed to record highs on Federal Reserve stimulus and stronger-than-expected earnings. The Dow Jones industrial average fell 13.62 points or 0.09 percent, to 15,556.66, the S&P 500 gained 0.15 point or 0.01 percent, to 1,759.92 and the Nasdaq Composite dropped 0.584 point, or 0.01 percent, to 3,942.777.

** CLOVIS ONCOLOGY INC, $62.04, up 10.3 pct (9:46 a.m. ET)

The cancer drug developer said on Sunday that interim data from an early-stage trial on its experimental lung cancer drug showed evidence of tumor shrinkage and was well-tolerated with no evidence of rash or dose-related diarrhea.

** CROCS INC, $13.06, down 4.5 pct (9:47 a.m. ET)

Brokerage Piper Jaffray cut its rating on the shoe maker's stock to "neutral" from "overweight," reported.